KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Shareholder's Equity Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 309.61%
Dec 31, 2025 154.17%
Sep 30, 2025 188.92%
Jun 30, 2025 26.02%
Mar 31, 2025 65.00%
Dec 31, 2024 -14.45%
Sep 30, 2024 -81.25%
Jun 30, 2024 0.00%
Mar 31, 2024 -44.17%
Dec 31, 2023 5.62%
Sep 30, 2023 -17.49%
Jun 30, 2023 -41.07%
Mar 31, 2023 -81.99%
Dec 31, 2022 -26.60%
Sep 30, 2022 -26.98%
Jun 30, 2022 -61.15%
Mar 31, 2022 -83.81%
Dec 31, 2021 528.38%
Sep 30, 2021 47.69%
Jun 30, 2021 -71.35%
Mar 31, 2021 50.34%
Dec 31, 2020 -29.17%
Sep 30, 2020 49.90%
Jun 30, 2020 49.13%
Mar 31, 2020 50.93%
Dec 31, 2019 39.28%
Sep 30, 2019 4.00%
Jun 30, 2019 2.32%
Mar 31, 2019 1.72%
Dec 31, 2018 -81.19%
Sep 30, 2018 -3.44%
Jun 30, 2018 -6.70%
Mar 31, 2018 -6.30%
Dec 31, 2017 -7.26%
Sep 30, 2017 -0.63%
Jun 30, 2017 -1.22%
Mar 31, 2017 -2.19%
Dec 31, 2016 2.20%
Sep 30, 2016 2.36%
Jun 30, 2016 1.61%
Mar 31, 2016 2.03%
Dec 31, 2015 1.89%
Sep 30, 2015 3.19%
Jun 30, 2015 -1.11%
Mar 31, 2015 -1.16%
Dec 31, 2014 -2.18%
Sep 30, 2014 -2.57%
Jun 30, 2014 -1.61%
Mar 31, 2014 -0.78%
Dec 31, 2013 -1.20%
Dec 31, 2012 -2.66%
Sep 30, 2012 -1.44%
Jun 30, 2012 4.30%